ArticleFrontiers in aging neuroscience2026
Distinct patterns of spontaneous brain activity in mild cognitive impairment patients stratified by cerebrospinal fluid biomarkers.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to explore the alterations in the Amplitude of Low-Frequency Fluctuation (ALFF) among mild cognitive impairment (MCI) patients with varying cerebrospinal fluid (CSF) biomarker levels, including abnormal Amyloid-beta (Aβ42) and phosphorylated tau protein (p-tau) (A + T +), abnormal Aβ42 and normal p-tau (A + T-), and normal Aβ42 and p-tau (A-T-), and to investigate their longitudinal changes. Methods: A total of 134 MCI patients were enrolled in this study and stratified into three groups, including 54 A-T- group, 28 A + T- group, and 52 A + T + group based on CSF Aβ and p-tau levels. The baseline ALFF values derived from blood oxygen level-dependent signals were employed to quantify spontaneous brain activity patterns. Comparisons were made among the three groups regarding ALFF differences, and their correlations with cognitive functions and CSF biomarkers were investigated. Additionally, a subset of participants with 2-year follow-up data underwent a mixed-effects model analysis to examine group-by-time interactions in ALFF. Results: At baseline, compared to the A-T- group, the A + T- group showed decreased ALFF in the bilateral cerebellar posterior lobe (CPL) and increased ALFF in the bilateral middle frontal gyrus (MFG), while the A + T + group displayed decreased ALFF in the bilateral CPL. In contrast to the A + T- group, the A + T + group exhibited decreased ALFF in the bilateral MFG. Additionally, there was a significant negative correlation between the bilateral MFG and p-tau levels, while the left MFG was positively correlated with RAVLT-learning performance, and the right MFGs was positively correlated with Aβ levels. Longitudinally, a significant group-by-time interaction was observed in the right inferior temporal gyrus (ITG), where A + T + patients exhibited a more pronounced ALFF decline over 2 years compared to A + T- patients. Conclusion: This study highlights distinct and evolving patterns of brain activity associated with Aβ and tau pathology in MCI. The combination of cross-sectional and longitudinal analyses reveals that tau pathology may drive accelerated functional decline in specific brain regions, particularly the right ITG, offering insights into the progression of AD-spectrum disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.